Neil Jones has been appointed as the new Chief Commercial Officer (CCO) of the Aenova Group.
 
As a member of the Executive Leadership Team (ELT), he manages Aenova’s commercial operations and will play a key role in shaping and expanding them.
  
Jones has extensive experience in the pharmaceutical and biotechnology industries in both product and service areas. Prior to joining Aenova, he was Vice President at Catalent Pharma Solutions and CEO and CBO at VMIC (Vaccine Manufacturing and Innovation Centre). Prior to that, he served as Director Business Development Europe at Catalent Pharma Solutions from 2016 to 2021 and previously held various positions at Patheon.
 
Jones holds a Bachelor of Science in Chemistry from the University of Bristol and a Post Graduate Certificate in Management from the University of the West of England.
 
“We are very pleased to welcome Neil to the team. Neil is a manager who is highly experienced in the pharmaceutical-biotechnology industry and is perfectly placed for the central position of CCO at Aenova,” commented CEO Jan Kengelbach on the appointment. “Neil will greatly enrich our team with his drive, his innovative ability and last but not least with his personal and human values.”